MRKR · Marker Therapeutics, Inc.
$1.14
+0.03 (+2.70%)
At close · Aug 14
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt regarding our ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$19.01M
Shares
16.67M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Juan Vera | President and Chief Executive Officer | $741,190 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Juan Vera | President and Chief Executive Officer | $400,000 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Peter Hoang | Former President and Chief Executive Officer | $582,394 |
| Juan Vera | President and Chief Executive Officer | $581,923 |
| Michael Loiacono | former Chief Accounting Officer | $566,515 |
| Mythili Koneru | our Former Chief Medical Officer | $220,146 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Former Chief | Financial Officer | $929,170 |
| Mythili Koneru | our Former Chief Medical Officer | $632,382 |
| Juan Vera | President and Chief Executive Officer | $581,923 |
| Peter Hoang | Former President and Chief Executive Officer | $556,170 |
| Michael Loiacono | former Chief Accounting Officer | $479,161 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Peter Hoang | Former President and Chief Executive Officer | $1,619,032 |
| Anthony Kim | Chief Financial Officer | $948,291 |
| Former Chief | Financial Officer | $948,291 |
| Mythili Koneru | Former Chief Medical Officer | $901,538 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Peter Hoang | President and Chief Executive Officer | $1,374,082 |
| Anthony Kim | Chief Financial Officer | $829,306 |
| Mythili Koneru | Chief Medical Officer | $782,200 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Mythili Koneru | Chief Medical Officer | $1,843,763 |
| Peter Hoang | President and Chief Executive Officer | $451,665 |
| Anthony Kim | Chief Financial Officer | $431,523 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Kathryn Penkus Corzo | Board | Appointed | 2025-11-05 |
| John Wilson | Director | Resigned | 2025-01-30 |
| Juan Vera | Principal Financial and Accounting Officer | Appointed | 2023-11-20 |
| Eliot M. Lurier | Interim Chief Financial Officer | Appointed | 2023-07-03 |
| Michael Loiacono | Chief Accounting Officer | Terminated | 2023-07-03 |
| Peter Hoang | President and Chief Executive Officer | Resigned | 2023-05-01 |
| Mythili Koneru | Chief Medical Officer | Resigned | 2023-03-16 |
| Anthony Kim | Chief Financial Officer | Terminated | 2022-09-27 |
| Frederick Wasserman | Chair of the Board | Terminated | 2022-04-06 |
| Frederick Wasserman | member of the board of directors | Terminated | 2022-04-06 |
Key facts
CIK
1094038
CUSIP
57055L206
13F (30d)
34 filings
34 filers
Visit website
Investor relations